PROFESSIONAL EDITION

The largest community of pharma leaders

Industry News

      MercachemSyncom Closes Acquisition of Alcami Weert

      NIJMEGEN & GRONINGEN, Netherlands--(BUSINESS WIRE)--MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, today announced that it has acquired Alcami’s European cGMP CMC drug...

      Personal Genome Diagnostics and Mayo Clinic Enter Strategic Collaboration to Enhance Patient Care in Oncology

      BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a strategic collaboration with Mayo Clinic to enhance the development of...

      ERS Genomics Announces Agreement With New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents

      DUBLIN & IPSWICH, Mass.--(BUSINESS WIRE)--ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr....

      Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride in Retinal Degeneration Treatment

      SEATTLE--(BUSINESS WIRE)--Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of...

      Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy  

      NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its previously announced divestment of its oral solid, biologics, and sterile product...

      Recent Articles